IL
Isomorphic Labs
United Kingdom · Biotech · AI
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
Funding history
2 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $5B | Greenoaks — LeadSequoia Capital — LeadAlphabet — ParticipantAndreessen Horowitz (a16z) — ParticipantCapitalG — ParticipantGV — ParticipantMGX — ParticipantTemasek — ParticipantThrive Capital — ParticipantUK Sovereign AI fund — Participant | |
| Series B | $2.1B | Alphabet — Role not disclosedCapitalG — Role not disclosedGV — Role not disclosedMGX — Role not disclosedTemasek — Role not disclosedThrive Capital — Role not disclosedUK Sovereign AI fund — Role not disclosed |